Author

Alan Cooper

Primary ORCID profile (0000-0002-7738-7851 · 10 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Alan CooperiD10 papers · South Australian Museum

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Brian D. BrowniD· 1 shared Daniel CharytonowicziD· 1 shared Gvantsa PantsulaiaiD· 1 shared Ivan OdakiD· 1 shared Jaime Mateus-TiqueiD· 1 shared Joanna K ChorazeczewskiiD· 1 shared Joshua BrodyiD· 1 shared Justin Paul KlineiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Brian D. BrownORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Potentiating CAR-T bystander killing by enhanced Fas/FasL signaling mitigates antigen escape in heterogeneous tumors

Matthew Junda Lin, Joanna K Chorazeczewski, Gvantsa Pantsulaia, Alan Cooper, Moah Sohn, Sidorela Reci, Jaime Mateus-Tique, Nicole H. Hirsh, Xin-Ping Xie, Ivan Odak, Rudra Prasad Dutta, Daniel Charytonowicz, Ranjan Upadhyay, Brian D. Brown, Miriam Mérad, , Joshua Brody

This study shows that enhancing Fas/FasL signaling improves CAR-T cell bystander killing against antigen-negative tumor cells, reducing antigen escape and improving therapeutic outcomes.

bioRxiv · Sep 22, 2025 · PreprintImmunology